Enhanced Data Quality in LC/MS/MS Analysis of Nitrosamines

Importance of the topic

Nitrosamines such as N-nitrosodimethylamine (NDMA) and N-nitrosodibutylamine (NDBA) are potent genotoxic impurities of high regulatory concern in pharmaceuticals. Reliable detection at sub-ng/mL levels in complex matrices is essential for product safety, regulatory compliance, and risk assessment. LC/MS/MS is the preferred analytical platform for nitrosamine screening because of its selectivity and sensitivity, but solvent- and system-derived background signals can mask trace analytes and bias quantitation. Effective mitigation of these background sources is therefore critical to achieve low detection limits and accurate results.

Objectives and study overview

This application note evaluated whether integrating an inline solvent purifier into an LC/MS/MS flow path improves data quality for trace nitrosamine analysis. The primary aims were to quantify baseline noise reduction, demonstrate detection of 0.1 ng/mL NDMA, and show elimination of NDBA interference originating from mobile phase or system contamination. Comparative experiments were performed with and without the Agilent InfinityLab quick change solvent purifier installed between the pump and autosampler.

Methodology

Key methodological features summarized from the study:

• LC/MS system: Agilent 1290 Infinity II LC coupled to an Agilent 6475 triple quadrupole MS.
• Chromatography: Agilent InfinityLab Poroshell 120 EC-C18, 3.0 × 100 mm; column temperature 40 °C; flow rate 0.5 mL/min; injection volume 20 µL.
• Mobile phases: A = 0.1% formic acid in water; B = 0.1% formic acid in methanol. A stepped gradient was applied to elute analytes and flush the column (initial high aqueous, ramp to high organic, re-equilibration).
• Ionization and detection: APCI in positive ion mode with multiple reaction monitoring (MRM) transitions for NDMA (precursor m/z 75.1 → product m/z 58.0 and 43.1) and NDBA (precursor m/z 159.2 → product m/z 57.1 and 41.1). Fragmentor and collision energies were optimized per transition.
• Comparative protocol: blank injections and 0.1 ng/mL standards analyzed with and without the solvent purifier to assess baseline and contamination effects.

Used instrumentation

Instrumentation and consumables specifically referenced:

• Agilent 1290 Infinity II LC system.
• Agilent 6475 triple quadrupole mass spectrometer.
• Agilent InfinityLab Poroshell 120 EC-C18 column, 3.0 × 100 mm (part number 695575-302).
• Agilent InfinityLab quick change solvent purifier, 3.0 × 75 mm (installed between pump and autosampler, part number 5067-1621).

Main results and discussion

Major findings and interpretation:

• Baseline noise reduction: Installation of the solvent purifier decreased baseline background by approximately seven-fold compared with the unpurified setup. This substantial lowering of background enabled reliable detection of NDMA at 0.1 ng/mL, which was undetectable without the purifier due to elevated baseline interference.
• Source of contamination: The study attributed a portion of the NDMA and NDBA background to the laboratory water and mobile phase components; the inline purifier effectively removed these solvent- and system-derived nitrosamine signals at the source.
• NDBA interference elimination: Blank runs without the purifier exhibited measurable NDBA signals (m/z 159.2 → 41.1) consistent with mobile-phase or system contamination, leading to potential overestimation of sample concentrations. After purifier installation, the interference peaks in blanks were eliminated while true 0.1 ng/mL NDBA standards remained detectable, improving quantitative accuracy.
• Multi-transition confirmation: Cleaner baselines improved signal clarity across multiple MRM transitions for each analyte, strengthening peak identification and confirmation criteria important for regulatory analyses.
• Workflow impact: The purifier is installed between pump and autosampler and requires minimal changes to existing LC/MS configurations while producing notable improvements in data quality.

Benefits and practical applications

Practical advantages demonstrated by this approach include:

• Improved sensitivity: Enabling detection of nitrosamines at or below 0.1 ng/mL by substantially lowering baseline noise.
• Enhanced quantitative reliability: Removal of solvent- and system-derived interferences reduces false positives/overestimation and the risk of false negatives.
• Operational simplicity: Inline solvent purification can be integrated with standard LC/MS/MS workflows with minimal hardware modification.
• Routine QC applicability: The method supports pharmaceutical quality-control laboratories that must routinely screen for trace nitrosamines to meet regulatory thresholds.

Future trends and potential uses

Potential developments and broader applications suggested by the findings:

• Wider adoption of inline solvent purification in trace-analysis workflows for other classes of volatile or low‑level contaminants (e.g., other nitrosamines, nitrosatable impurities, volatile organics).
• Integration with automated solvent handling and monitoring systems to provide continuous solvent quality control and automated alerts for contamination.
• Extension to other ionization sources and mass-spectrometer platforms to assess universal benefits across analytical setups (e.g., ESI, different triple quadrupoles, high-resolution MS).
• Standardization and regulatory recognition: incorporation of solvent purification steps into validated methods and regulatory guidance for nitrosamine testing.
• Complementary measures: continued emphasis on routine blank injections, system suitability testing, and source-of-contamination tracing to maintain low detection limits and method robustness.

Conclusion

Adding an inline solvent purifier between the LC pump and autosampler demonstrably improves LC/MS/MS data quality for nitrosamine analysis by removing solvent- and system-derived background signals. The purifier reduced baseline noise by roughly seven-fold, enabling detection of NDMA at 0.1 ng/mL and removing NDBA interference that would otherwise bias quantitation. This straightforward hardware modification offers a practical, low-effort path to enhance sensitivity, selectivity, and confidence in trace-level nitrosamine testing in pharmaceutical QA/QC laboratories.

References

Agilent Technologies. Enhanced Data Quality in LC/MS/MS Analysis of Nitrosamines Using the Agilent InfinityLab quick change solvent purifier. Application Note by Linda Lin and Rong-Jie Fu, Agilent Technologies (Shanghai) Co., Ltd., June 2026. DE-014840, document 5994-9264EN.